TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Nov 25, 2020 15:26 JST
Source:
Toyota Motor Corporation
Toyota Begins Sales of "Shodoku Taishi" Foot-Operated Sanitizer Stands
Contributing to society with monozukuri (manufacturing) capabilities
Toyota City, Japan, Nov 25, 2020 - (JCN Newswire) - Toyota Motor Corporation announces the release of "Shodoku Taishi," a foot-operated sanitizer stand that will be available through Toyota dealers nationwide, starting December 1. Amidst the spread of COVID-19, Toyota has leveraged its on-site monozukuri (manufacturing) capabilities and the Toyota Production System (TPS), which support its desire to create ever-better cars, to produce masks and face shields, develop vehicles that control the circulation of airborne droplets, and provide support to raise productivity in the production of protective gowns for healthcare use as part of the Toyota Group's Kokoro Hakobu Project.(1)
The foot-operated sanitizer stand that Toyota is launching at this time was first produced in early April under the initiative of employees at Toyota plants, who wanted to take action and prevent infections among their colleagues, where operation of production lines was unavoidably suspended due to the COVID-19 pandemic. Based on a desire to contribute to society with the foot-operated sanitizer stands, the TPS professionals who participated in the medical protective gown project later became involved, commercialization was investigated, a prototype was brought to a healthcare institution, and a final model was determined based on the opinions of experts. The stand has been put into use at healthcare institutions and some dealers, as well as large commercial facilities and local government offices in Aichi Prefecture, and various opinions were received from customers regarding concerns about its effectiveness, sanitation, and weight. These opinions were reflected in subsequent versions, and the stand was modified so that parts can be removed for cleaning, to enable use by wheelchair users, and to reduce the weight from approximately 6 kg of the first version to about 3.2 kg (including the mat). Utilizing the technology and know-how it has cultivated in car manufacturing, Toyota has produced about 30 versions of prototypes and has made thorough improvements in preparation for its commercialization.
The development team insisted on creating a product that is easy for anyone to use and is good quality at an affordable price, and named the high-quality but inexpensive sanitizer stand the "Shodoku Taishi" (sanitizer ambassador). Monthly production of 2,000 to 2,500 units commenced at the Kamigo Parts Center, and sales through Toyota vehicle dealers and Toyota Rent-a-Lease dealers in Japan will commence on December 1.
These actions are a part of Toyota's initiatives to provide goods and services that bring happiness to the people of the world in accordance with President Akio Toyoda's declaration that "Toyota will earnestly strive to achieve the target of sustainable development and the Sustainable Development Goals (SDGs), which are being pursued by the international society with the aim of 'leaving no one behind'." In other words, it is an effort to "producing happiness for all."(2) Toyota is committed to contributing to society through manufacturing of high-quality, inexpensive products that provide peace of mind and safety throughout the world.
Main Specifications
Width x Depth x Height 330 mm x 430 mm x 1,169 mm
Weight Approximately 3.2 kg (including mat)
Manufacturer's suggested retail price 8,000 yen (not including consumption tax)
(1) The Kokoro Hakobu Project (with "Kokoro Hakobu" meaning "to carry or deliver one's heart" in Japanese) has been the collective name of nationwide initiatives by Toyota, Toyota sales outlets in Japan, and their employees to provide continuous and long-term support to disaster-affected areas in the wake of the Great East Japan Earthquake. The name has the connotation of "carrying you in our hearts." Based on Toyota's desire to contribute in some way to people who have contracted and are suffering from COVID-19, as well as to the medical professionals, Japan's central government and local governments in Japan fighting the disease night and day, Toyota has decided to apply the Kokoro Hakobu Project as its overall moniker for related support activities conducted by companies of the Toyota Group working together.
(2) Toyota's Philosophy
https://global.toyota/en/company/vision-and-philosophy/philosophy/
Source: Toyota Motor Corporation
Sectors: Automotive
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Related Press Release
Pushing Hydrogen Engine Technology to New Heights in the Super Taikyu Series Final Race
November 17 2025 23:00 JST
Toyota to Invest Up to $10 Billion Additional in Its U.S. Operations Over the Next Five Years
November 13 2025 23:08 JST
World Premiere of the New Hilux in Asia
November 10 2025 19:29 JST
Immersive Museum "THE MOVEUM YOKOHAMA by TOYOTA GROUP" to Open on December 20, 2025
October 23 2025 22:27 JST
New Land Cruiser "FJ" Makes World Premiere
October 21 2025 20:29 JST
Sumitomo Metal Mining and Toyota Collaborate on Mass Production of Cathode Materials for All-Solid-State Batteries
October 09 2025 19:40 JST
Toyota Launches Strategic Investment Subsidiary and Woven Capital Fund II to Accelerate Transformation into a Mobility Company
September 30 2025 18:34 JST
Toyota Announces Sales, Production, and Export Results for August 2025
September 29 2025 14:11 JST
Isuzu and Toyota to Jointly Develop Next-Generation Fuel Cell Route Bus
September 29 2025 13:42 JST
Toyota Woven City Officially Launches as a Test Course for the Future of Mobility
September 26 2025 18:18 JST
More Press release >>
Latest Press Release
The 26th Hong Kong Forum marks successful completion
Dec 03, 2025 22:44 JST
Mitsubishi Motors Launches the All-New Destinator in Vietnam
Dec 03, 2025 18:00 JST
Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15
Dec 03, 2025 11:30 JST
Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025
Dec 03, 2025 00:01 JST
NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI
Dec 02, 2025 23:43 JST
Fujitsu develops new technology to support human-robot collaboration
Dec 02, 2025 23:26 JST
Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks
Dec 02, 2025 22:55 JST
Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms
Dec 01, 2025 23:04 JST
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
Dec 01, 2025 22:43 JST
Fujitsu launches 'Fujitsu Accelerator Program for SPORTS' to create new value through Sports x Technology
Dec 01, 2025 22:14 JST
Eisai Submits New Drug Application for Subcutaneous Formulation of "LEQEMBI(R)" for the Treatment of Early Alzheimer's Disease in Japan
Nov 28, 2025 23:00 JST
JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information
Nov 28, 2025 19:41 JST
MHI Publishes "MHI REPORT 2025" and "SUSTAINABILITY DATABOOK 2025"
Nov 28, 2025 19:05 JST
Sharp Wins IAM's "Asia IP Elite 2025", Awarded to Companies with Outstanding Intellectual Property Strategy for The Second Consecutive Year
Nov 28, 2025 18:36 JST
Fujitsu builds platform for NSK to create environmental value throughout the product lifecycle of bearing products
Nov 28, 2025 18:01 JST
Fujitsu launches Japan Edition of SAP Fioneer Cloud for Insurance, a next-generation platform supporting core business operations in the Japanese insurance industry
Nov 28, 2025 17:28 JST
NEC Launches Sales Support Solution Utilizing Agentic AI
Nov 27, 2025 22:31 JST
Fujitsu and Yamaguchi University develop low-power edge computing technology for near real-time image processing on small satellites
Nov 27, 2025 22:00 JST
World's first ever spiral escalator renewal project conducted at a commercial facility in Mexico
Nov 27, 2025 11:00 JST
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) IQLIK(TM) (lecanemabirmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
Nov 26, 2025 19:42 JST
More Latest Release >>